Literature DB >> 9123520

Anti-CD45RB treatment prolongs islet allograft survival in mice.

L A Auersvald1, D M Rothstein, S C Oliveira, C Q Khuong, G P Basadonna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9123520     DOI： 10.1016/s0041-1345(96)00478-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

1.  A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells.

Authors:  Hui Qi; Jin-Peng Liu; Chun-Yan Deng; Han-Xin Zhou; Shao-Ping Deng; Fu-Rong Li
Journal:  Immunol Res       Date:  2012-06       Impact factor: 2.829

2.  An immunosufficient murine model for the study of human islets.

Authors:  Gaoping Zhao; Daniel J Moore; James I Kim; Kang Mi Lee; Matthew O'Connor; Maozhu Yang; Andrew F Marshall; Ji Lei; Christian Schuetz; James F Markmann; Shaoping Deng
Journal:  Xenotransplantation       Date:  2014-07-09       Impact factor: 3.907

3.  Inhibition of ICAM-1/LFA-1 interactions prevents B-cell-dependent anti-CD45RB-induced transplantation tolerance.

Authors:  Xiaolun Huang; Daniel J Moore; Mohammad Mohiuddin; Moh-Moh Lian; James I Kim; Samsher Sonawane; Jing Wang; Yi Gu; Heidi Yeh; James F Markmann; Shaoping Deng
Journal:  Transplantation       Date:  2008-03-15       Impact factor: 4.939

4.  An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells.

Authors:  Silvia Gregori; Patrizia Mangia; Rosa Bacchetta; Eleonora Tresoldi; Frank Kolbinger; Catia Traversari; Josè M Carballido; Jan E de Vries; Ulf Korthäuer; Maria-Grazia Roncarolo
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.